Sun Pharma Presents New Clinical Efficacy and Safety Data in Severe Dermatological Conditions at the 2024 European Academy of Dermatology and Venereology (EADV) Congress
Press Release Sep 26 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
- Press Release Sep 06 2024
- Press Release Aug 23 2024
- Press Release Jul 26 2024
- Press Release Jul 16 2024
Later from Sun Pharmaceutical Industries
- Press Release Oct 01 2024
- Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUN
- Press Release Oct 15 2024
- Press Release Oct 25 2024
- Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries